| NCT ID | NCT07424469 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Baylor Research Institute |
| Condition | Gastrointestinal Diseases |
| Study Type | INTERVENTIONAL |
| Enrollment | 50 participants |
| Start Date | 2020-08-14 |
| Primary Completion | 2026-07-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 50 participants in total. It began in 2020-08-14 with a primary completion date of 2026-07-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Aims 1. To understand the microbial composition involved with foregut leaks 2. To define the virulence changes in the microbiota following foregut leaks 3. To identify host response mechanisms and how they change with interventions 4. Utilize this information to improve patient outcomes
Eligibility Criteria
Inclusion Criteria: * Patients with an esophageal or stomach leak * Over 18 years old Exclusion Criteria: * Patients determined by physician/surgeon as not able to tolerate biopsy * Under 18 years old
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07424469 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Gastrointestinal Diseases. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07424469 currently recruiting?
Yes, NCT07424469 is actively recruiting participants. Contact the research team at Rehma.Shabbir@BSWHealth.org for enrollment information.
Where is the NCT07424469 trial being conducted?
This trial is being conducted at Dallas, United States.
Who is sponsoring the NCT07424469 clinical trial?
NCT07424469 is sponsored by Baylor Research Institute. The trial plans to enroll 50 participants.